Cardiovascular risk in rheumatological diseases: an underestimated clinical priority
Main Article Content
Article Sidebar
Published
2025 December 30
Jorge Hernández
Luis Dulcey
Jaime Gómez-Ayala
Juan Therán
https://orcid.org/0009-0001-5758-5965
Luis Dulcey
Jaime Gómez-Ayala
Juan Therán
Abstract
Las enfermedades reumatológicas de carácter sistémico, como el lupus eritematoso sistémico (LES), la artritis reumatoide (AR), las espondiloartritis (Spa) y ciertas vasculitis primarias, representan condiciones complejas que trascienden el aparato musculoesquelético. Uno de los aspectos más relevantes y, al mismo tiempo, subestimados es su abordaje clínico en el riesgo cardiovascular (RCV) asociado. La evidencia científica actual demuestra que estos pacientes presentan una incidencia significativamente mayor de eventos aterotrombóticos, en comparación con la población general, incluso en edades tempranas y en ausencia de factores de riesgo tradicionales.
How to Cite
1.
Hernández J, Dulcey L, Gómez-Ayala J, Therán J. Cardiovascular risk in rheumatological diseases: an underestimated clinical priority. Rev. parag. reumatol. [Internet]. 2025 Dec. 30 [cited 2026 Oct. 9];11(2):93-4. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/234
Downloads
Download data is not yet available.
Article Details
References
(1) Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American heart association. Circulation [Internet]. 2016;134(23):e579–646. Disponible en: http://dx.doi.org/10.1161/CIR.0000000000000455
(2) Lyu Q, Ma L, Liu H, Wang J. Meta-analysis of risk factors for cardiovascular disease in patients with rheumatoid arthritis. Medicine (Baltimore) [Internet]. 2023;102(45):e35912. Disponible en: http://dx.doi.org/10.1097/MD.0000000000035912
(3) Løgstrup BB, Ellingsen T, Pedersen AB, Darvalics B, Olesen KKW, Bøtker HE, et al. Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population. Rheumatology (Oxford) [Internet]. 2021;60(3):1400–9. Disponible en: http://dx.doi.org/10.1093/rheumatology/keaa374
(4) Kawano Y, Weber BN, Weisenfeld D, Jeffway MI, Cai T, McDermott GC, et al. Risk of incident heart failure and heart failure subtypes in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) [Internet]. 2025;77(5):631–9. Disponible en: http://dx.doi.org/10.1002/acr.25481
(5) England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ [Internet]. 2018;361:k1036. Disponible en: http://dx.doi.org/10.1136/bmj.k1036
(6) Løgstrup BB, Olesen KKW, Masic D, Gyldenkerne C, Thrane PG, Ellingsen T, et al. Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease. Ann Rheum Dis [Internet]. 2020;79(9):1182–8. Disponible en: http://dx.doi.org/10.1136/annrheumdis-2020-217154
(7) Schattner A. The cardiovascular burden of rheumatoid arthritis - implications for treatment. Am J Med [Internet]. 2023;136(12):1143–6. Disponible en: http://dx.doi.org/10.1016/j.amjmed.2023.09.004
/j.amjmed.2023.09.004
(2) Lyu Q, Ma L, Liu H, Wang J. Meta-analysis of risk factors for cardiovascular disease in patients with rheumatoid arthritis. Medicine (Baltimore) [Internet]. 2023;102(45):e35912. Disponible en: http://dx.doi.org/10.1097/MD.0000000000035912
(3) Løgstrup BB, Ellingsen T, Pedersen AB, Darvalics B, Olesen KKW, Bøtker HE, et al. Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population. Rheumatology (Oxford) [Internet]. 2021;60(3):1400–9. Disponible en: http://dx.doi.org/10.1093/rheumatology/keaa374
(4) Kawano Y, Weber BN, Weisenfeld D, Jeffway MI, Cai T, McDermott GC, et al. Risk of incident heart failure and heart failure subtypes in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) [Internet]. 2025;77(5):631–9. Disponible en: http://dx.doi.org/10.1002/acr.25481
(5) England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ [Internet]. 2018;361:k1036. Disponible en: http://dx.doi.org/10.1136/bmj.k1036
(6) Løgstrup BB, Olesen KKW, Masic D, Gyldenkerne C, Thrane PG, Ellingsen T, et al. Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease. Ann Rheum Dis [Internet]. 2020;79(9):1182–8. Disponible en: http://dx.doi.org/10.1136/annrheumdis-2020-217154
(7) Schattner A. The cardiovascular burden of rheumatoid arthritis - implications for treatment. Am J Med [Internet]. 2023;136(12):1143–6. Disponible en: http://dx.doi.org/10.1016/j.amjmed.2023.09.004
/j.amjmed.2023.09.004
Section
LETTERS TO THE EDITOR
How to Cite
1.
Hernández J, Dulcey L, Gómez-Ayala J, Therán J. Cardiovascular risk in rheumatological diseases: an underestimated clinical priority. Rev. parag. reumatol. [Internet]. 2025 Dec. 30 [cited 2026 Oct. 9];11(2):93-4. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/234
Share
